You may feel like you’re going to die — but you’re not. Your body is right here in this safe place and we are monitoring you ...

Latest NHS statistics say 1,846,533 people aged 15-29 were prescribed antidepressants in 2023, compared with 1,404,138 in ...

Frontline healthcare workers struggling with depression after the COVID-19 pandemic experienced significant relief from a ...

As part of panel of experts convened by the U.S Food and Drug Administration (FDA), Case Western Reserve University professor Lee Hoffer voted last week to recommend a new nasal spray for ...

A clinical LSD formulation shows promise for severe anxiety. Trials reveal meaningful symptom relief and limited side effects ...

Investors reacted positively to news that the company was using a $50 million private placement to help fund a Phase 3 study.

Herriot Tabuteau combined his Yale medical degree and two decades in finance to start Axsome Therapeutics. Now the company ...

A futuristic fix for depression is here — and it doesn’t involve prescription drugs or a shrink. The first-of-its-kind solution from GrayMatters Health uses something called “self-neuromodulation” to ...

A recent study found that a single dose of LSD effectively treated symptoms of anxiety for an astonishing 12 weeks.

A new study suggests that a person’s genetic predisposition for chronic inflammation helps define a specific subtype of ...

A new large-scale analysis found that the short-term cardiovascular and metabolic side effects of antidepressants vary widely ...

The American Psychiatric Association offers a revamped approach to depression. Oct. 1, 2010— -- The American Psychiatric Association has issued an update to its 10-year-old treatment guidelines ...